Yoon CK, Oh J, Bae K, Park UC, et al. Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trial. PLoS One 2022;17:e0275611.
PMID: 36374913